Recent Updates
Recently added Catalysts
MXCT Positive Sentiment Score: 70/100

MaxCyte to Participate in Baird Global Healthcare Conference

Tuesday, September 5, 2023 1 min read
Key Takeaway: MaxCyte, a prominent cell-engineering company, announced its participation in the Baird Global Healthcare Conference scheduled for September 13th at 2:35 p.m. Eastern Time. The event aims to showcase advancements in cell-based research and therapeutic discovery. Investors can access a live and archived webcast of the event through the company's investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is actively engaging in the healthcare community by participating in industry events.
  • The company's focus on innovative cell-based research positions it as a leader in cell-engineering.
  • The availability of live and archived webcasts enhances transparency and accessibility for investors.

Full Press Release Details

ROCKVILLE, Md., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced Company management will participate at the Baird Global Healthcare Conference on Wednesday, September 13th at 2:35 p.m. Eastern Time.
A live and archived webcast of the event will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Spectrum Seismic Collaborative
valerie@spectrumscience.com
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
Consilium Strategic Communications
maxcyte@consilium-comms.com

Frequently Asked Questions

When will MaxCyte participate in the Baird Global Healthcare Conference?

MaxCyte will participate on September 13th at 2:35 p.m. Eastern Time.

Where can I find the webcast of the Baird conference?

The webcast will be available on the Events section of MaxCyte's investor relations website.

What is MaxCyte focused on?

MaxCyte specializes in cell-engineering technologies to support cell-based research.

What is MaxCyte's stock ticker symbol?

MaxCyte's stock is listed as NASDAQ: MXCT and LSE: MXCT.

Who can I contact for more information about MaxCyte?

For inquiries, you can contact Valerie at Spectrum Seismic Collaborative.

Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte Baird Global Healthcare Conference cell-engineering NASDAQ: MXCT live webcast
Last updated: Sep 5, 2023